Stage IVA Prostate Cancer AJCC v8 Terminated Phase 2 Trials for Enzalutamide (DB08899)

IndicationStatusPhase
DBCOND0109674 (Stage IVA Prostate Cancer AJCC v8)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03999515Erdafitinib and Abiraterone Acetate or Enzalutamide in Treating Patients With Double Negative Prostate CancerTreatment